Nina E. Landvik

788 total citations
17 papers, 656 citations indexed

About

Nina E. Landvik is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Nina E. Landvik has authored 17 papers receiving a total of 656 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Immunology and 6 papers in Cancer Research. Recurrent topics in Nina E. Landvik's work include Cell death mechanisms and regulation (4 papers), Immune Response and Inflammation (4 papers) and Carcinogens and Genotoxicity Assessment (3 papers). Nina E. Landvik is often cited by papers focused on Cell death mechanisms and regulation (4 papers), Immune Response and Inflammation (4 papers) and Carcinogens and Genotoxicity Assessment (3 papers). Nina E. Landvik collaborates with scholars based in Norway, France and United Kingdom. Nina E. Landvik's co-authors include Shanbeh Zienolddiny, Aage Haugen, Vidar Skaug, Xavier Tekpli, Dominique Lagadic‐Gossmann, Jørn A. Holme, Morgane Gorria, Anita Solhaug, Volker M. Arlt and Nana Asare and has published in prestigious journals such as Biochemical and Biophysical Research Communications, International Journal of Cancer and Carcinogenesis.

In The Last Decade

Nina E. Landvik

17 papers receiving 646 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nina E. Landvik Norway 14 316 174 124 112 110 17 656
Iwona Sidorkiewicz Poland 15 235 0.7× 169 1.0× 106 0.9× 82 0.7× 117 1.1× 39 619
Mario Venza Italy 15 360 1.1× 77 0.4× 74 0.6× 85 0.8× 78 0.7× 26 615
Meng Guo China 16 315 1.0× 156 0.9× 56 0.5× 137 1.2× 107 1.0× 32 704
Xiaonian Zhu China 15 309 1.0× 142 0.8× 100 0.8× 86 0.8× 159 1.4× 65 633
Kelie Chen China 13 313 1.0× 176 1.0× 90 0.7× 115 1.0× 109 1.0× 37 624
Xi Huang China 17 340 1.1× 107 0.6× 53 0.4× 139 1.2× 199 1.8× 45 711
Li Xiao China 17 265 0.8× 78 0.4× 101 0.8× 192 1.7× 58 0.5× 49 791
Tsung‐Ho Ying Taiwan 15 308 1.0× 131 0.8× 58 0.5× 89 0.8× 77 0.7× 45 646
Liyan Sun China 16 290 0.9× 175 1.0× 74 0.6× 54 0.5× 50 0.5× 36 776

Countries citing papers authored by Nina E. Landvik

Since Specialization
Citations

This map shows the geographic impact of Nina E. Landvik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nina E. Landvik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nina E. Landvik more than expected).

Fields of papers citing papers by Nina E. Landvik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nina E. Landvik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nina E. Landvik. The network helps show where Nina E. Landvik may publish in the future.

Co-authorship network of co-authors of Nina E. Landvik

This figure shows the co-authorship network connecting the top 25 collaborators of Nina E. Landvik. A scholar is included among the top collaborators of Nina E. Landvik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nina E. Landvik. Nina E. Landvik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Landvik, Nina E., et al.. (2018). Criteria for grouping of manufactured nanomaterials to facilitate hazard and risk assessment, a systematic review of expert opinions. Regulatory Toxicology and Pharmacology. 95. 270–279. 18 indexed citations
2.
Tekpli, Xavier, et al.. (2012). DNA methylation at promoter regions of interleukin 1B, interleukin 6, and interleukin 8 in non-small cell lung cancer. Cancer Immunology Immunotherapy. 62(2). 337–345. 82 indexed citations
3.
Tekpli, Xavier, Nina E. Landvik, Vidar Skaug, et al.. (2012). Functional effect of polymorphisms in 15q25 locus on CHRNA5 mRNA, bulky DNA adducts and TP53 mutations. International Journal of Cancer. 132(8). 1811–1820. 11 indexed citations
4.
Landvik, Nina E., et al.. (2012). Molecular characterization of a cancer‐related single nucleotide polymorphism in the pro‐inflammatory interleukin‐1B gene. Molecular Carcinogenesis. 51(S1). E168–75. 21 indexed citations
5.
Landvik, Nina E., et al.. (2012). Functional analysis of a lung cancer risk haplotype in the IL1B gene regulatory region. Journal of Human Genetics. 57(11). 747–752. 10 indexed citations
6.
Landvik, Nina E., et al.. (2010). A combination of functional polymorphisms in the CASP8, MMP1, IL10 and SEPS1 genes affects risk of non-small cell lung cancer. Lung Cancer. 71(2). 123–129. 62 indexed citations
7.
Skretting, Grethe, Benedicte Stavik, Nina E. Landvik, et al.. (2010). Functional characterization of polymorphisms in the human TFPI gene. Biochemical and Biophysical Research Communications. 397(1). 106–111. 13 indexed citations
8.
Landvik, Nina E., Shanbeh Zienolddiny, Vidar Skaug, & Aage Haugen. (2010). Gene variants and lung cancer risk. BMC Proceedings. 4(S2). 1 indexed citations
9.
Zienolddiny, Shanbeh, Vidar Skaug, Nina E. Landvik, et al.. (2009). The TERT-CLPTM1L lung cancer susceptibility variant associates with higher DNA adduct formation in the lung. Carcinogenesis. 30(8). 1368–1371. 83 indexed citations
10.
Landvik, Nina E., Volker M. Arlt, Eszter Nagy, et al.. (2009). 3-Nitrobenzanthrone and 3-aminobenzanthrone induce DNA damage and cell signalling in Hepa1c1c7 cells. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 684(1-2). 11–23. 27 indexed citations
11.
Tekpli, Xavier, Edgar Rivedal, Morgane Gorria, et al.. (2009). The B[a]P-increased intercellular communication via translocation of connexin-43 into gap junctions reduces apoptosis. Toxicology and Applied Pharmacology. 242(2). 231–240. 29 indexed citations
12.
Asare, Nana, Xavier Tekpli, Mary Rissel, et al.. (2009). Signalling pathways involved in 1-nitropyrene (1-NP)-induced and 3-nitrofluoranthene (3-NF)-induced cell death in Hepa1c1c7 cells. Mutagenesis. 24(6). 481–493. 16 indexed citations
13.
Landvik, Nina E., et al.. (2009). A specific interleukin-1B haplotype correlates with high levels of IL1B mRNA in the lung and increased risk of non-small cell lung cancer. Carcinogenesis. 30(7). 1186–1192. 67 indexed citations
14.
Gorria, Morgane, Xavier Tekpli, Maryvonne Rissel, et al.. (2008). A new lactoferrin- and iron-dependent lysosomal death pathway is induced by benzo[a]pyrene in hepatic epithelial cells. Toxicology and Applied Pharmacology. 228(2). 212–224. 27 indexed citations
15.
Asare, Nana, Nina E. Landvik, Dominique Lagadic‐Gossmann, et al.. (2008). 1-Nitropyrene (1-NP) induces apoptosis and apparently a non-apoptotic programmed cell death (paraptosis) in Hepa1c1c7 cells. Toxicology and Applied Pharmacology. 230(2). 175–186. 40 indexed citations
16.
Holme, Jørn A., Morgane Gorria, Volker M. Arlt, et al.. (2007). Different mechanisms involved in apoptosis following exposure to benzo[a]pyrene in F258 and Hepa1c1c7 cells. Chemico-Biological Interactions. 167(1). 41–55. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026